Evidence map›Paper›PMID 30105827›Full record

ArticleCNS neuroscience & therapeutics2018

Motor neuron disease-like phenotype associated with anti-IgLON5 disease.

Qing-Qing Tao, Qiao Wei, Shui-Jiang Song, Xin-Zhen Yin

Abstract readCase ReportsLetter
In one paragraph

Article in CNS neuroscience & therapeutics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Anti-IgLON5 Disease 10 Years Later: What We Know and What We Do Not Know.Neurology(R) neuroimmunology & neuroinflammation · 2025
    Review
  6. Recent advances in autoimmune encephalitis.Arquivos de neuro-psiquiatria · 2024
    Review
  7. The presence and clinical significance of autoantibodies in amyotrophic lateral sclerosis: a narrative review.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2024
    Review
  8. Article
  9. Phenotypic Insights Into Anti-IgLON5 Disease in IgLON5-Deficient Mice.Neurology(R) neuroimmunology & neuroinflammation · 2024
    Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Anti-IgLON5 Disease: A New Bulbar-Onset Motor Neuron Mimic Syndrome.Neurology(R) neuroimmunology & neuroinflammation · 2021
    Article
  16. Sleep Disturbances Associated with Neurological Autoimmunity.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2021
    Review
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Qing-Qing TaoDepartment of Neurology and Research Center of Neurology, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Qiao WeiDepartment of Neurology and Research Center of Neurology, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Shui-Jiang SongDepartment of Neurology and Research Center of Neurology, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Xin-Zhen YinDepartment of Neurology and Research Center of Neurology, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.ORCID 0000-0001-9063-4012

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AntibodiesCell Adhesion Molecules, NeuronalElectromyographyHumansMagnetic Resonance ImagingMaleMiddle AgedMotor Neuron DiseaseAntibodiesCell Adhesion Molecules, NeuronalIgLON5 protein, human

Identifiers

PMID30105827
PMCPMC6490080

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.